ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Drug Bills Cut $500 Million From Cancer Care, ASCO Says.

July 4, 2003

In Brief: Rhoads, Schmidt Bow Out – Amos, Krim Possible Replacements; Sibal acting Virology Director

January 27, 1978

Funding Opportunities

October 18, 2002

Revlimid Maintenance Therapy Delayed Progression by 90%

May 27, 2011

Richard Pestell, of Georgetown University, to direct Kimmel Cancer Center at Thomas Jefferson University.

November 11, 2005

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002